Related Experiment Video
Updated: Aug 15, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Outlook: finding improved medicines: the role of academic-industrial collaboration
Jaye Chin-Dusting1, Jacques Mizrahi, Garry Jennings
1Alfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute, Commercial Road, Melbourne 3004, Australia. jaye.chin-dusting@baker.edu.au
Abstract:
This paper reviews models of academic-pharmaceutical industry collaboration and debates the value of such partnerships so that those contemplating an alliance can reflect a priori on the purpose, nature and process that will provide a constructive outcome. The scope is confined to the biomedical discipline, because collaborations in other fields, such as physics and engineering, have not suffered as a result of the concerns associated with biomedicine.
Related Concept Videos
Drug Discovery: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Preclinical Development: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmacogenomics: Identification of New Drug Targets
